Fecal Microbiota Transplantation for Treatment of Gastrointestinal Dysbiosis Clearance of ARO
Status:
Active, not recruiting
Trial end date:
2020-08-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to assess the efficacy of FMTs via enema for 1) symptom
improvement in individuals with a formal diagnosis of dysbiosis due to active inflammatory
bowel disease or irritable bowel syndrome; 2) clearance of antimicrobial resistant organism
from the gastrointestinal tract.